Clinical Report: Colonizing Corneal Healing

Overview

Researchers have developed a novel approach to treating corneal injury: genetically engineered bacteria that colonize the eye and deliver anti-inflammatory therapy directly to the ocular surface, reported in Cell Reports. This strategy uses a modified commensal microbe to release interleukin-10 (IL-10), a cytokine known for its potent immunoregulatory effects, to promote corneal epithelial repair.

Background

Corneal injuries are a significant cause of emergency room visits, accounting for around 3% of ER visits and affecting over one million individuals annually in the U.S. Delayed healing can lead to severe complications, including infection and vision loss. Traditional topical medications often fail to provide sustained therapeutic effects due to rapid clearance from the ocular surface.

Data Highlights

Key Findings

• Genetically engineered Corynebacterium mastitidis can deliver IL-10 directly to the ocular surface.
• The engineered bacteria significantly accelerated corneal epithelial wound closure in preclinical models.
• Local inflammation was reduced with the application of IL-10–producing microbes.
• This approach may provide a sustained delivery system for anti-inflammatory agents, unlike traditional eye drops.
• The method could be adapted for various ocular surface disorders driven by inflammation, although it remains at a preclinical stage.

Clinical Implications

The use of engineered ocular microbes represents a promising advancement in treating corneal injuries and other inflammatory ocular conditions. This strategy may reduce the need for frequent dosing of topical medications and improve patient outcomes through sustained therapeutic effects, potentially applicable to a range of ocular surface disorders.

Conclusion

The development of live biotherapeutics for ocular applications could transform the management of corneal injuries and other inflammatory disorders, offering a novel approach to enhance healing and restore immune balance on the ocular surface, with significant implications for human treatment.

Related Resources & Content

1. Contact Lens Spectrum, SPARE THE CAUTION, SPOIL THE GRAFT, 2019 -- Specialty lens options for visual rehabilitation in post-penetrating keratoplasty patients
2. Ophthalmology Management, Neurotrophic Keratopathy: New Treatment Strategies, 2012 -- New treatment strategies for neurotrophic keratopathy
3. Contact Lens Spectrum, Treatment Plan, 2014 -- Managing corneal grafts
4. Ophthalmology Management — Clinical Utility of Amniotic Membranes